REG - CVS Group plc - Transaction in Own Shares
Tue 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251230:nRSd0415Na&default-theme=true
RNS Number : 0415N CVS Group plc 30 December 2025
30 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 29 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 29/12/2025
Aggregate number of Ordinary Shares purchased: 15,260
Lowest price paid per share (GBp): 1,268.00
Highest price paid per share (GBp): 1,282.00
Volume weighted average price paid per share (GBp): 1,276.03
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,719,089 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,719,089 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 1,021,694 Ordinary Shares in aggregate at a weighted average price
of 1,220.60 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
198 1268 29/12/2025 08:08:11 1360740812328148 XLON
176 1274 29/12/2025 08:13:02 1360740812328646 XLON
83 1274 29/12/2025 08:55:22 1360740812332264 XLON
497 1278 29/12/2025 09:42:27 1360740812334977 XLON
62 1280 29/12/2025 10:05:29 1360740812335948 XLON
6 1280 29/12/2025 10:05:29 1360740812335949 XLON
345 1280 29/12/2025 10:05:29 1360740812335950 XLON
56 1280 29/12/2025 10:05:29 1360740812335951 XLON
11 1280 29/12/2025 10:05:29 1360740812335952 XLON
307 1280 29/12/2025 10:05:39 1360740812335974 XLON
88 1280 29/12/2025 10:05:39 1360740812335976 XLON
463 1282 29/12/2025 12:56:28 1360740812343152 XLON
195 1282 29/12/2025 12:56:28 1360740812343156 XLON
87 1280 29/12/2025 13:05:00 1360740812343460 XLON
75 1278 29/12/2025 13:29:54 1360740812344473 XLON
69 1278 29/12/2025 14:04:16 1360740812346231 XLON
202 1276 29/12/2025 14:06:30 1360740812346387 XLON
119 1276 29/12/2025 14:06:30 1360740812346389 XLON
87 1274 29/12/2025 14:41:08 1360740812350514 XLON
492 1274 29/12/2025 14:54:02 1360740812352121 XLON
445 1274 29/12/2025 14:54:02 1360740812352126 XLON
120 1268 29/12/2025 14:56:00 1360740812352438 XLON
1 1268 29/12/2025 15:05:09 1360740812353413 XLON
290 1272 29/12/2025 15:11:39 1360740812354279 XLON
186 1272 29/12/2025 15:17:48 1360740812355199 XLON
186 1272 29/12/2025 15:17:48 1360740812355200 XLON
6 1272 29/12/2025 15:17:48 1360740812355201 XLON
6 1272 29/12/2025 15:17:48 1360740812355203 XLON
180 1272 29/12/2025 15:17:48 1360740812355202 XLON
186 1272 29/12/2025 15:17:48 1360740812355204 XLON
186 1272 29/12/2025 15:17:48 1360740812355205 XLON
186 1272 29/12/2025 15:17:48 1360740812355206 XLON
18 1272 29/12/2025 15:17:48 1360740812355207 XLON
100 1272 29/12/2025 15:17:48 1360740812355208 XLON
68 1272 29/12/2025 15:17:48 1360740812355209 XLON
272 1272 29/12/2025 15:17:48 1360740812355210 XLON
186 1272 29/12/2025 15:17:48 1360740812355211 XLON
186 1272 29/12/2025 15:17:48 1360740812355212 XLON
186 1272 29/12/2025 15:32:11 1360740812356793 XLON
186 1272 29/12/2025 15:32:11 1360740812356801 XLON
304 1272 29/12/2025 15:32:11 1360740812356802 XLON
186 1272 29/12/2025 15:32:11 1360740812356803 XLON
304 1272 29/12/2025 15:32:11 1360740812356804 XLON
165 1272 29/12/2025 15:32:11 1360740812356805 XLON
9 1272 29/12/2025 15:32:11 1360740812356806 XLON
12 1272 29/12/2025 15:32:11 1360740812356807 XLON
3 1272 29/12/2025 15:32:11 1360740812356808 XLON
186 1272 29/12/2025 15:32:11 1360740812356809 XLON
159 1272 29/12/2025 15:32:11 1360740812356810 XLON
27 1272 29/12/2025 15:32:12 1360740812356811 XLON
186 1272 29/12/2025 15:32:13 1360740812356819 XLON
68 1272 29/12/2025 15:32:13 1360740812356820 XLON
280 1272 29/12/2025 15:32:13 1360740812356821 XLON
186 1272 29/12/2025 15:51:36 1360740812359028 XLON
534 1276 29/12/2025 15:56:27 1360740812359851 XLON
1426 1276 29/12/2025 15:58:55 1360740812360376 XLON
186 1276 29/12/2025 15:58:55 1360740812360372 XLON
1 1276 29/12/2025 16:07:13 1360740812361680 XLON
49 1280 29/12/2025 16:11:46 1360740812362249 XLON
6 1280 29/12/2025 16:11:46 1360740812362250 XLON
108 1280 29/12/2025 16:11:46 1360740812362251 XLON
120 1280 29/12/2025 16:11:46 1360740812362252 XLON
7 1280 29/12/2025 16:11:46 1360740812362248 XLON
260 1280 29/12/2025 16:11:46 1360740812362253 XLON
190 1280 29/12/2025 16:11:46 1360740812362254 XLON
60 1280 29/12/2025 16:11:46 1360740812362255 XLON
186 1280 29/12/2025 16:11:46 1360740812362256 XLON
186 1280 29/12/2025 16:11:46 1360740812362257 XLON
186 1280 29/12/2025 16:11:46 1360740812362258 XLON
186 1280 29/12/2025 16:11:46 1360740812362259 XLON
186 1280 29/12/2025 16:11:46 1360740812362260 XLON
186 1280 29/12/2025 16:11:46 1360740812362261 XLON
186 1280 29/12/2025 16:11:46 1360740812362262 XLON
186 1280 29/12/2025 16:11:46 1360740812362263 XLON
186 1280 29/12/2025 16:11:46 1360740812362264 XLON
186 1280 29/12/2025 16:11:46 1360740812362265 XLON
186 1280 29/12/2025 16:11:46 1360740812362266 XLON
186 1280 29/12/2025 16:11:46 1360740812362267 XLON
186 1280 29/12/2025 16:11:46 1360740812362268 XLON
169 1280 29/12/2025 16:11:46 1360740812362269 XLON
853 1278 29/12/2025 16:11:46 1360740812362272 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSPPGUWPUPAGMB
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
Announcement